JPS6225989A - Production of phosphatidylcholine having high content of gamma-linolenic acid - Google Patents
Production of phosphatidylcholine having high content of gamma-linolenic acidInfo
- Publication number
- JPS6225989A JPS6225989A JP60165303A JP16530385A JPS6225989A JP S6225989 A JPS6225989 A JP S6225989A JP 60165303 A JP60165303 A JP 60165303A JP 16530385 A JP16530385 A JP 16530385A JP S6225989 A JPS6225989 A JP S6225989A
- Authority
- JP
- Japan
- Prior art keywords
- linolenic acid
- phosphatidylcholine
- gamma
- mortierella
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 title claims abstract description 24
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 title claims abstract description 24
- 229960002733 gamolenic acid Drugs 0.000 title claims abstract description 24
- 235000020664 gamma-linolenic acid Nutrition 0.000 title claims abstract description 23
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 title claims abstract description 19
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 150000002632 lipids Chemical class 0.000 claims abstract description 35
- 241000235575 Mortierella Species 0.000 claims abstract description 9
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 8
- 235000014633 carbohydrates Nutrition 0.000 claims description 8
- 230000000813 microbial effect Effects 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 22
- 238000000605 extraction Methods 0.000 abstract description 22
- 241000306282 Umbelopsis isabellina Species 0.000 abstract 1
- 241000907980 Umbelopsis nana Species 0.000 abstract 1
- 241000180122 Umbelopsis vinacea Species 0.000 abstract 1
- 229940098330 gamma linoleic acid Drugs 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 29
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 239000002609 medium Substances 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 241000233866 Fungi Species 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- -1 etc. Chemical compound 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔技術分野〕
本発明はγ−リノレン酸含量の高いホスファチジルコリ
ンのモルティエレラ属糸状菌による製造方法に関するも
のである。DETAILED DESCRIPTION OF THE INVENTION [Technical Field] The present invention relates to a method for producing phosphatidylcholine with a high content of γ-linolenic acid using a filamentous fungus of the genus Mortierella.
、パモルティエレラ属に属するイサベリナ、ビナセア、
ラマニアナ、ラマニアナ・アングリスポラ、J、1′
及びナナ等の糸状菌体を、高濃度の炭水化物を炭素源と
する培地に培養することにより、γ−リノレン酸含有脂
質含量の高い菌体を高密度で生産する方法は既に提案さ
nている。(特願昭59−22394号)。, Isabelina, Vinacea, belonging to the genus Pamoltierella;
By culturing filamentous fungi such as L. Lamaniana, L. Methods of production have already been proposed. (Patent Application No. 59-22394).
ところで、グリセロ型リン脂質の一種類であるホスファ
チジルコリンは次式の様な構造を持つことが知られてい
る。By the way, phosphatidylcholine, which is a type of glycerophospholipid, is known to have a structure as shown in the following formula.
CHrOCOP。CHrOCOP.
CH−OCOR’
その構造脂肪酸であるRCOOHあるいはR,’C0O
Hにγ−リノレン酸含量が20%以上含むホスファチジ
ルコリンが微生物から製造単離濃縮された従来技術は存
在しない。CH-OCOR' Its structural fatty acid is RCOOH or R,'C0O
There is no prior art in which phosphatidylcholine containing 20% or more of γ-linolenic acid in H is produced, isolated and concentrated from microorganisms.
本発明は、γリルン酸含量の高いホスファチ−2= ジルコリンの製造方法を提供することを目的とする。 The present invention provides phosphati-2= The purpose of the present invention is to provide a method for producing zircoline.
即ち、本発明によれば、γ−リノレン酸含量の高いホス
ファチジルコリンの生産にあたり、モルティエレラ属に
属するイサベリナ、ビナセア、ナナ、ラマニアナ、ラマ
ニアナ・アングリスポラ又はナナの糸状菌菌株を高濃度
の炭水化物を炭素源とした培地に培養して、培地中に高
密度に得られるγ−1ツノl/ン酸を含む脂質の高含量
菌体より抽出されたγ−リノレン酸含有脂質の、特に多
段抽出(特願昭60−1.0283号)における第1段
アルコール抽出区分イから効率よくγ−リノレン酸含量
の高いホスファチジルコリンを、例えばクロマトグラフ
ィーなどで分離、濃縮することを特徴とするγ−リノレ
ン酸含量の高いホスファチジルコリンの製造方法が提供
される。That is, according to the present invention, in producing phosphatidylcholine with a high content of γ-linolenic acid, a filamentous fungal strain of Isabelina, Vinacea, Nana, Lamaniana, Lamaniana anglispora or Nana belonging to the genus Mortierella is used to use a high concentration of carbohydrates as a carbon source. Especially multi-stage extraction (patent application A method for efficiently separating and concentrating phosphatidylcholine having a high γ-linolenic acid content from the first stage alcohol extraction section A in No. 60-1.0283) by, for example, chromatography. A method for producing phosphatidylcholine is provided.
本発明においては、用いる使用菌はモルティエレラ(M
ortierella )属のイサベリナ(isabe
−aniana)(IFO8287)、ラマニアナ・ア
ングリスポラ(ramaniana var、 ang
lispora) (IFO8187:]の各種菌株で
ある。々お、上記した菌はいずれも財団法人発酢研究所
に保存され、IFOカタログ(菌株目録)に記載されて
いる糸状菌である。In the present invention, the bacteria used is Mortierella (M
ortierella) genus Isabelina
-anniana) (IFO8287), Ramaniana angrispora (ramaniana var, ang
lispora) (IFO8187:]. All of the above-mentioned bacteria are filamentous fungi that are kept at the Hatsu Hatsu Research Institute and are listed in the IFO Catalog (Strain Catalog).
上記の糸状菌を培養する培地の炭麦源である炭水化物と
しては、たとえばグルコース、フラクトース、サッカロ
ース、糖蜜、デン粉、木材糖什液などが用いら扛る。炭
水化物は培地11中に20〜400g用いられるのが好
ましい。また窒素源としては、例えば硝酸アンモニウム
、硫酸アンモニウム、塩什アンモニウム、リン酸アンモ
ニウムなどの様な無機窒素源、または尿素、ペプトン、
酵母エキス、コーン、スチーブ・リカーなど有機窒素源
が用いらnる。無機塩としては、例えばKH2PO4;
K2HPO4,NaC7、FeSO4,7H□0 、
Maso4’7H20,ZnSO4・7H20などが
用いられる。その他必要に応じて微量要素、その他の栄
養源を添加する。Examples of carbohydrates used as the charcoal source of the medium for culturing the filamentous fungi include glucose, fructose, saccharose, molasses, starch, and wood syrup. Preferably, 20 to 400 g of carbohydrates are used in the medium 11. Examples of nitrogen sources include inorganic nitrogen sources such as ammonium nitrate, ammonium sulfate, ammonium chloride, ammonium phosphate, etc., or urea, peptone,
Organic nitrogen sources such as yeast extract, corn, and stave liquor can be used. Examples of inorganic salts include KH2PO4;
K2HPO4, NaC7, FeSO4,7H□0,
Maso4'7H20, ZnSO4.7H20, etc. are used. Add trace elements and other nutritional sources as necessary.
上記糸状菌の培養は通常液体培地で、振とう培養、通気
攪拌培養などにより行われる。培地のpHは3.0〜6
.0が良く、通常2日〜10日間位培養が行われる。更
に、培養の初期すなわち初期培地に、また通気攪拌培養
の場合では前培養培地に、あるいは培養の中間段階で酢
酸あるいは酢酸塩(ナトリウム塩、カリウム塩などのア
ルカリ金属塩)を炭素源濃度など培養条件に応じて0.
1〜20 g/l培地の割合で加えることにより菌体の
培養が行われる(特願昭59−1 i5162)。かく
して、培養物中にγ−リノレン酸など不飽和脂肪酸含量
が高い脂質の高含量菌体が生産性高く生産されるので、
培養物より菌体を分離し、脂質が糸状菌菌体中に含まわ
るので、この菌体よりγ−リノレン酸など不飽和脂肪酸
含量の高い脂質を採取するのが好適である。培養物より
菌体の分離に当っては菌糸があまりのびず極めて小単位
(1〜10細胞)で培養さ−ζ −
゛率約60チ)になる利点を有することが明らかになっ
た。The above-mentioned filamentous fungi are usually cultured in a liquid medium by shaking culture, aerated agitation culture, or the like. The pH of the medium is 3.0-6
.. 0 is good, and culture is usually carried out for about 2 to 10 days. Furthermore, acetic acid or acetate salts (alkali metal salts such as sodium salts and potassium salts) are added to the initial culture medium, in the case of aerated agitation culture, to the preculture medium, or in the intermediate stage of culture to increase the concentration of carbon sources, etc. 0 depending on conditions.
Culture of bacterial cells is carried out by adding 1 to 20 g/l of the medium (Japanese Patent Application No. 1982-1-5162). In this way, bacterial cells with a high content of lipids with a high content of unsaturated fatty acids such as γ-linolenic acid are produced with high productivity.
Since the cells are separated from the culture and lipids are contained in the filamentous cells, it is preferable to collect lipids with a high content of unsaturated fatty acids such as γ-linolenic acid from the cells. It has become clear that when separating the bacterial cells from the culture, the hyphae do not spread too much and can be cultured in extremely small units (1 to 10 cells) with a rate of about 60 cells.
γ−リノレン酸含景の高い脂質の採取は多段抽出方法で
行われる。すなわち、本発明においては、モルティエレ
ラ、属糸状菌体を、先ず、水の存在下、アルコールを用
いる第1抽出処理工程において抽出処理する。この場合
、処理原料として用いる菌体には、培地から遠心分離法
や濾過法によって分離された含水率50〜80係程度の
含水菌体ケーキや、その乾燥物を用いることができるが
、経済性の点からは、含水菌体ケーキを用いるのが有利
である。また、この第1抽出処理工程では、菌体は、水
の存在下、アルコール溶媒中で、機械力を加えて破砕さ
せることが必要であり、この菌体破砕によって効率的な
抽出処理が達成される。このような菌体破砕を伴う抽出
装置としては、従来公知の湿式粉砕機、例えば、ボール
ミル、マサツ円板ミ−、ル、ヘンセルミキザー等を用い
ることができる。Collection of lipids with a high content of γ-linolenic acid is carried out using a multi-stage extraction method. That is, in the present invention, Mortierella filamentous fungi are first extracted in the first extraction step using alcohol in the presence of water. In this case, as the bacterial cells used as the raw material for treatment, it is possible to use a hydrated bacterial cake with a water content of about 50 to 80, separated from the culture medium by centrifugation or filtration, or a dried product thereof, but it is not economical. From this point of view, it is advantageous to use a water-containing bacterial cell cake. In addition, in this first extraction treatment step, it is necessary to crush the bacterial cells by applying mechanical force in the presence of water and in an alcohol solvent, and efficient extraction treatment is achieved by crushing the bacterial cells. Ru. As such an extraction device that involves crushing the bacterial cells, a conventionally known wet grinder such as a ball mill, a Masatsu disk mill, a Hensel mixer, etc. can be used.
1:“1゛
むこのような粉砕機により菌体は、圧縮力やマザッ鴨等
の機械力を受け、その一部が破損ないし破砕される。こ
の場合、菌体を余りにも微細に破砕することは好ましく
なく、濾過性の点からは、その菌体の粒径は実質上変化
しない程度に機械力を加えるのが好ましい。アルコール
溶媒としては、通常、メタノール、エタノール、プロパ
ツール等の低級アルコ−ルが用いられるが、人体に対す
る安全性の点から、エタノールの使用が好ましい。アル
コール溶媒の使用割合は、菌体1重量部(乾燥物基準)
に対し、2〜7重量部、好ましくは3〜6重量部の割合
である。この第1抽出処理工程では、極性脂質を溶出さ
せるために、水の存在下で抽出処理を行うことが必要で
あり、水の存在量は、アルコール溶媒1重量に対し、0
.2〜0,7重量部、好址しくけ0.3〜0.6重量部
である。この第1抽出処理系に対する水の添加は、水を
含む菌体を用いて実施し得る他、アルコール溶媒に添加
することによって行うことができる。このような抽出槽
脂質回収率は、全脂質回収率に対し、通常、5〜30重
量弼、好ましくは8〜25重量係である。1: With such a crusher, the bacterial cells are subjected to compressive force or mechanical force such as mechanical force, and some of them are damaged or crushed.In this case, the bacterial cells are crushed too finely. From the viewpoint of filterability, it is preferable to apply mechanical force to such an extent that the particle size of the bacterial cells does not substantially change.As the alcohol solvent, lower alcohols such as methanol, ethanol, and propatool are usually used. However, from the point of view of safety for the human body, it is preferable to use ethanol.The proportion of alcohol solvent used is 1 part by weight of bacterial cells (dry basis).
The ratio is 2 to 7 parts by weight, preferably 3 to 6 parts by weight. In this first extraction process, in order to elute polar lipids, it is necessary to perform the extraction process in the presence of water, and the amount of water present is 0 per 1 weight of alcohol solvent.
.. The amount is 2 to 0.7 parts by weight, and the suitable amount is 0.3 to 0.6 parts by weight. Addition of water to this first extraction treatment system can be carried out using microbial cells containing water, or can be carried out by adding it to an alcohol solvent. The extraction tank lipid recovery rate is usually 5 to 30 weight percent, preferably 8 to 25 weight percent, relative to the total lipid recovery rate.
次に、前記で得た第1抽出生成物は第1固液分離工程で
破砕菌体成分と極性脂質を含むアルコール溶媒成分とに
それぞれ分離される。この場合、固液分離法としては、
遠心分離法や、濾過分離法等の慣用の方法が採用される
。脂質分は得られた極性脂質を含むアルコール溶媒成分
から常法に従って減圧下で、溶媒を蒸留留去することに
より得られる。Next, the first extraction product obtained above is separated into a crushed bacterial cell component and an alcohol solvent component containing polar lipids in a first solid-liquid separation step. In this case, the solid-liquid separation method is
Conventional methods such as centrifugation and filtration separation methods are employed. The lipid component can be obtained by distilling off the solvent from the alcohol solvent component containing the obtained polar lipid under reduced pressure in accordance with a conventional method.
前記多段抽出方法のアルコールを溶媒とした第1段目の
抽出操作により得られた脂質成分について吸着カラムク
ロマトグラフィ法による分離操作を行うことによりγ−
リノレン酸含量の高いホスファチジルコ11ンは分離、
精製される。mVち、50〜300メツシユ、好ましく
はlOO〜200メツ智[ユのケイ酸(シリカゲル)、
微粒多孔質シリカ、1札
シリカゲル■、シリカゲルG、ケイ酸マグネシウミー
ム′などを充填剤としたカラムを用いて、ヘキサン、シ
クロヘキサン、四塩化炭素、ベンゼン、クロロホルム、
ジエチルエーテル、酢酸エチル、アセトン、アセトニト
リル、メタノール、酢酸水を溶媒として用いて溶媒の極
性に応じて、一種類ないし2〜3種類混合した溶媒、例
えば、クロロホルムとメタノール4:1.3:2.1:
1.1:2混合溶媒などを順次流下することにより、各
極性脂質の吸着力の差により分離溶出が可能になり、γ
−リノレン哨含量の高いホスファチジルコリンが分離さ
れて含まれる溶出液を得る。この溶出液から常法により
溶媒を減圧下で蒸留留去することにより、γ−リノレン
酸含量の高いホスファチジルコリンが濃縮されることを
見出した。γ-
Phosphatidylco-11, which has a high content of linolenic acid, is separated,
Refined. mV, 50 to 300 mV, preferably lOO to 200 mV, silicic acid (silica gel),
Hexane, cyclohexane, carbon tetrachloride, benzene, chloroform,
Diethyl ether, ethyl acetate, acetone, acetonitrile, methanol, and aqueous acetic acid are used as solvents, depending on the polarity of the solvent, and a mixture of one or two or three solvents is used, for example, chloroform and methanol 4:1.3:2. 1:
1. By sequentially flowing a 1:2 mixed solvent, etc., separation and elution is possible due to the difference in adsorption power of each polar lipid, and γ
- An eluate containing phosphatidylcholine with a high linolenic content is obtained. It has been found that phosphatidylcholine with a high content of γ-linolenic acid can be concentrated by distilling off the solvent from this eluate under reduced pressure using a conventional method.
かくして、本発明によりは高濃度の炭水化物を炭素源と
する培地に高密度に培養された脂質含量の高い菌体より
採取された脂質からγ−リノレン酸含量の高いホスファ
チジルコリンの製造が可能−ル酸と共に哺乳動物では食
飼として要求される必須脂肪酸である。こnはγ〜リル
ン酸が体内テヒスホモーγ−リノレン酸となり、さらに
はアラキドン酸となる前駆体であること、ビスホモ−γ
−リノレン酸、アラキドン酸はそtぞゎプロスタグラン
ジン、E、 、 F、a及びE2 + F2aとなり生
体中で極めて重要な生理的な役割をはたしているからで
ある。従って、γ−リノレン酸含有脂質は医薬品などと
して利用できるものであることは明らかである。Thus, according to the present invention, it is possible to produce phosphatidylcholine with a high content of γ-linolenic acid from lipids collected from bacterial cells with a high lipid content cultured at high density in a medium containing a high concentration of carbohydrates as a carbon source. It is also an essential fatty acid required by mammals as part of their diet. This means that γ-linolenic acid is a precursor that becomes Tehishomo-γ-linolenic acid and then arachidonic acid, and bishomo-γ-linolenic acid.
- This is because linolenic acid and arachidonic acid become prostaglandins, E, F, a, and E2 + F2a, and play extremely important physiological roles in living organisms. Therefore, it is clear that γ-linolenic acid-containing lipids can be used as pharmaceuticals.
とくに、γ−リノレン酸は生体内ではリン脂質として蓄
線されていることが知られており、プロスタグランジン
になる際の前駆体としてはリン脂質状態の方がより有効
に作用するものと考えらゎることからこのようにγ−リ
ノレン酸含竜が2゜チ以上と高いホスファチジルコリン
の医薬品としての用途は十分期待できる。In particular, it is known that γ-linolenic acid is stored as a phospholipid in living organisms, and it is thought that the phospholipid state acts more effectively as a precursor for turning into prostaglandins. Therefore, phosphatidylcholine, which has a high content of γ-linolenic acid of 2° or more, can be fully expected to be used as a pharmaceutical.
チョコレートなどに用いられている。Used in chocolate, etc.
次に本発明を実施例により詳細に説明する。 Next, the present invention will be explained in detail with reference to examples.
実施例
グルコース60g、KH2PO42、!9、M、9’5
047 H2O0,3g、NaC10,1、!i’ 、
−=r ルト・エキ、’、 0.2 g、イースト−
1キス0.2g、ペプトyO,Iji、FeSO4゜7
H7H2O10、Mn5O+ −4H2Oi、ompと
窒素源として(NH4)2SO43g、(C/N比(炭
素源中の炭素原子重量/♀素温源中窒素原子重量)は約
40〕を脱イオン水1000rnlに混合した培地を基
準として炭素源である炭水化物(グルコース、糖など)
の濃度を増加させた場合、その濃度に応じて培地成分を
増加して、又窒素源を尿素などに変えた場合は同じC7
N比になるように培地を調整した。Example Glucose 60g, KH2PO42,! 9, M, 9'5
047 H2O0.3g, NaC10.1,! i',
-=r Luto Equi, ', 0.2 g, Yeast -
1 kiss 0.2g, Pepto yO, Iji, FeSO4゜7
H7H2O10, Mn5O+ -4H2Oi, omp and 3 g of (NH4)2SO4 as a nitrogen source, (C/N ratio (weight of carbon atoms in carbon source/weight of nitrogen atoms in elementary temperature source) is approximately 40) were mixed in 1000 rnl of deionized water. Carbohydrates (glucose, sugar, etc.) that are carbon sources based on the culture medium
If the concentration of C7 is increased, the medium components are increased accordingly, and the nitrogen source is changed to urea etc.
The medium was adjusted to have the same N ratio.
この培地を301の培養槽では20A仕込み、それぞれ
菌株を接種し、30℃の培養温度で所定地中の炭水化物
濃度の測定を行うため、培養の中間段階において所定の
時間毎に100 mlずつ試料の採取を行い、口過法に
より菌体と培地の分離を行った。分離された菌体はその
一部を含水率の定量のため、精秤し恒温槽中120℃で
一昼夜乾燥し、含水率を求め、残りの菌体について脂質
の抽出を行った。菌体からの脂質の抽出は、残りの湿菌
体にクロロホルム−メタノール(2: I V/V)混
液を加え、ガラスピーズ存在下にホモジナイズすること
により菌体の破砕と脂質の抽出を同時に行った。なお、
抽出を完全に行うため、これを5回繰返し、全抽出液を
集めた。上記抽出液1Flochの分配洗浄法により精
製した後、溶媒を減圧留去し、重量法で全脂質量を測定
した。菌体を除いた培地については高速液体クロマトグ
ラフィー(HP LC)により炭水什物(グルコース、
フラクトース、サッカロース)の濃度を測定し、濃度が
06738、モルティエレラ・イサベリナIFO782
4について、グルコースを炭素源、尿素を窒素源とした
301培養槽により培養して得られた菌体増殖量(乾燥
重量g/l)、脂質生成量<g/lj )、脂質含量(
チ)、脂質中のγ−リノレン酸含量を表−1にまとめて
示した。なお培養時間として示した時間は炭素源である
グルコースが完全に消費され、培地中になくなった時間
でありその時間で培養を停止した。This medium was charged to 20A in culture tank 301, and each strain was inoculated, and in order to measure the carbohydrate concentration in the specified soil at a culture temperature of 30°C, 100 ml of the sample was added at specified intervals during the intermediate stage of culture. A sample was taken, and the bacterial cells and the medium were separated by the mouth filtration method. A portion of the isolated bacterial cells was accurately weighed and dried in a constant temperature bath at 120° C. for a day and night to determine the moisture content, and the remaining bacterial cells were extracted for lipids. To extract lipids from the bacterial cells, add a chloroform-methanol (2:IV/V) mixture to the remaining wet bacterial cells and homogenize in the presence of glass beads to simultaneously crush the bacterial cells and extract the lipids. Ta. In addition,
To ensure complete extraction, this was repeated 5 times and all extracts were collected. After purification using the above extract 1Floch distribution washing method, the solvent was distilled off under reduced pressure, and the total lipid amount was measured gravimetrically. Carbohydrates (glucose, glucose,
The concentration of fructose, sucrose) was measured and the concentration was 06738, Mortierella Isabelina IFO782.
Regarding 4, the amount of bacterial cell growth (dry weight g/l), lipid production <g/lj), lipid content (
H) The γ-linolenic acid content in lipids is summarized in Table 1. Note that the time shown as the culture time is the time when glucose, which is a carbon source, is completely consumed and disappears in the medium, and the culture was stopped at that time.
表−1で3菌株ともγ−リノレン酸を含む脂質が生産性
高く生産されていることがわかる。Table 1 shows that all three strains produce lipids containing γ-linolenic acid with high productivity.
脱水分離し、含水率50〜70チの菌体ブロック(ケー
キ)を得る。この菌体ブロック(以下、湿菌体と呼ぶ)
をオートクレーブ中で120℃、2気圧で10分間減菌
した後、以下に示すようにして脂質の抽出を行った。Dehydrate and separate to obtain a bacterial block (cake) with a moisture content of 50 to 70 cm. This bacterial block (hereinafter referred to as wet bacterial body)
After sterilization in an autoclave at 120° C. and 2 atm for 10 minutes, lipids were extracted as shown below.
前記の湿菌体1,0〜1.7kgを、内容積61のステ
ンレス製ボールミルに入れ、さらにエタノール21を溶
媒として加え、4時間ボールミルにより菌体を破砕しな
がら抽出処理を行った。抽出液を螺退した後、得られた
菌体(含水率3.4%)について再度ヘキサン21を溶
媒として用い、前記と同様の抽出処理を7時間行った。1.0 to 1.7 kg of the wet bacterial cells were placed in a stainless steel ball mill with an internal volume of 61 kg, ethanol 21 was added as a solvent, and extraction was performed for 4 hours while crushing the bacterial cells in the ball mill. After screwing off the extract, the obtained bacterial cells (water content 3.4%) were subjected to the same extraction treatment as above for 7 hours using hexane 21 as a solvent again.
前記2段抽出方法による3菌株についての第1段のエタ
ノールによる脂質の対菌体抽出率が表−2に示されてい
る。Table 2 shows the extraction ratio of lipids to bacterial cells by ethanol in the first stage for the three bacterial strains obtained by the two-stage extraction method.
このエタノール抽出脂質について、下記の方法によるケ
イ酸(100〜200メツシユ)を充填剤−] 4−
に脂質を吸着させた後、中性脂質をクロロホルムで糖脂
質をアセトン、クロロホルム、メタノール4:1及び同
1:1溶出液でホスファチジルコリン以外のリン脂質を
流出した後、クロロホルム、メタノール2:3を溶出液
として溶出する区分を得た。得られた区分について薄層
クロマトグラフィーによる分析の結果ホスファチジルコ
リンが純度はぼ100%に濃縮されていることを認めた
。For this ethanol-extracted lipid, silicic acid (100 to 200 mesh) was adsorbed to the filler by the following method.Then, the neutral lipid was absorbed with chloroform, and the glycolipid was dissolved with acetone, chloroform, and methanol (4:1). After eluting phospholipids other than phosphatidylcholine with the same 1:1 eluent, a section was obtained that was eluted using chloroform and methanol 2:3 as an eluent. Analysis of the obtained fraction by thin layer chromatography revealed that phosphatidylcholine was concentrated to approximately 100% purity.
3菌株についてエタノール抽出脂質量に対する抽出率は
表−2の如く6.9〜80チと比較的高い値であり、乾
燥菌体に対する抽出率は0.32〜0.46チであった
。As shown in Table 2, the extraction rates of the three strains relative to the amount of ethanol-extracted lipids were relatively high, ranging from 6.9 to 80 inches, and the extraction rates relative to dry bacterial bodies were 0.32 to 0.46 inches.
このホスファチジルコリンについて加水分解した後、メ
チルエステル什を行い、その脂肪酸組成を比べた結果γ
−リノレン酸含量が25.7%以上と中性脂質区分の約
7%と異なり極めて高い値がυノール酸含量が高い特殊
な脂肪酸組成を有するものであることが明らかになった
。After hydrolyzing this phosphatidylcholine, we performed methyl ester and compared the fatty acid composition.
-It was revealed that the extremely high linolenic acid content of 25.7% or more, which is different from about 7% in the neutral lipid category, has a special fatty acid composition with a high υnolic acid content.
Claims (1)
、ラマニアナ、ラマニアナ・アングリスポラ又はナナの
菌株による高濃度の炭水化物を炭素源とする培地に高密
度に培養された脂質含量の高い菌体より採取された脂質
からγ−リノレン酸含量の高いホスファチジルコリンを
分離、濃縮することを特徴とするγ−リノレン酸含量の
高いホスファチジルコリンの製造方法。(1) Lipids collected from microbial cells with high lipid content cultured at high density in a medium containing high-concentration carbohydrates as a carbon source by strains of Isabelina, Vinacea, Lamaniana, Lamaniana anglispora, or Nana belonging to the genus Mortierella. 1. A method for producing phosphatidylcholine with a high content of γ-linolenic acid, which comprises separating and concentrating phosphatidylcholine with a high content of γ-linolenic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60165303A JPS6225989A (en) | 1985-07-26 | 1985-07-26 | Production of phosphatidylcholine having high content of gamma-linolenic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60165303A JPS6225989A (en) | 1985-07-26 | 1985-07-26 | Production of phosphatidylcholine having high content of gamma-linolenic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6225989A true JPS6225989A (en) | 1987-02-03 |
JPS6345200B2 JPS6345200B2 (en) | 1988-09-08 |
Family
ID=15809768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60165303A Granted JPS6225989A (en) | 1985-07-26 | 1985-07-26 | Production of phosphatidylcholine having high content of gamma-linolenic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6225989A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60168391A (en) * | 1984-02-09 | 1985-08-31 | Agency Of Ind Science & Technol | Production of gamma-linolenic acid-containing lipid and gamma- linolenic acid |
-
1985
- 1985-07-26 JP JP60165303A patent/JPS6225989A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60168391A (en) * | 1984-02-09 | 1985-08-31 | Agency Of Ind Science & Technol | Production of gamma-linolenic acid-containing lipid and gamma- linolenic acid |
Also Published As
Publication number | Publication date |
---|---|
JPS6345200B2 (en) | 1988-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0246324B1 (en) | Method for obtaining lipids from fungus bodies | |
Zhu et al. | Extraction of lipids from Mortierella alpina and enrichment of arachidonic acid from the fungal lipids | |
JPS6312290A (en) | Production of lipid containing arachidonic acid | |
US5246842A (en) | Production of eicosapentaenoic acid from filamentous fungi utilizing lactose as a primary carbon source | |
JPH0365948B2 (en) | ||
EP1035211B1 (en) | PROCESS FOR PRODUCING ARACHIDONIC ACID-CONTAINING LIPID AND DIHOMO-gamma-LINOLENIC ACID-CONTAINING LIPID | |
JP3630344B2 (en) | Process for producing inositol stereoisomers | |
JPS6225989A (en) | Production of phosphatidylcholine having high content of gamma-linolenic acid | |
Sagisaka et al. | Enzymic reduction of α-aminoadipic acid by yeast enzyme | |
JPS5933354B2 (en) | Production method of coenzyme Q | |
JPS6244917B2 (en) | ||
JPH0216989A (en) | Production of omega6-based unsaturated fatty acid-containing phospholipid | |
US5026644A (en) | Process for preparing a lipid composition having a high γ-linolenic acid content | |
JP3123789B2 (en) | Method for producing fats and oils and microorganisms therefor | |
JP4246056B2 (en) | Method for producing cerebroside | |
EP1285968B1 (en) | Selective transesterification of stanols in mixtures comprising sterols and stanols | |
JPH022594B2 (en) | ||
DE102010008353B4 (en) | Archaea and lipid compositions obtained therefrom | |
JPS6119235B2 (en) | ||
US4871666A (en) | Process for preparing a lipid composition having upon saponification a high gama-linolenic acid content | |
JPH06245759A (en) | Microorganism having oil and fat productivity and production of oil and fat | |
Campbell et al. | Role of cinnamate in benzoate production in Penicillium brevicompactum | |
JPS62296885A (en) | Production of palmitoleic acid | |
JPS63287491A (en) | Production of lipid component with high palmitoleic acid content | |
KR101589825B1 (en) | Method of enrichment highly purified stearidonic acid form from echium oil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |